![Stacy Coen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stacy Coen
Företagsledare/Principal på
IMMUNOGEN, INC.
Förmögenhet: 435 $ per 2026-05-31
Profil
Stacy A. Coen is Chief Business Officer & Senior Vice President at ImmunoGen, Inc. since 2020.
Current roles also include Member at Massachusetts Biotechnology Council, Trustee at Huntington's Disease Society of America, and Member at Alliance for Regenerative Medicine.
Former positions include Independent Director at FibroBiologics, Inc. from 2021 to 2026, Vice President at Genzyme Corp., and Vice President-Business Development at Editas Medicine, Inc. Education includes undergraduate studies at the University of Massachusetts and an MBA from the University of Virginia Darden School of Business.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
FIBROBIOLOGICS, INC. 0,01 % | 2026-04-24 | 375 ( 0,01 % ) | 435 $ | 2026-05-31 |
Aktiva positioner av Stacy Coen
| Företag | Position | Start |
|---|---|---|
| IMMUNOGEN, INC. | Företagsledare/Principal | 2020-06-03 |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Företagsledare/Principal | - |
Massachusetts Biotechnology Council
 Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Företagsledare/Principal | - |
Huntington's Disease Society of America | Direktör/Styrelseledamot | - |
Tidigare kända positioner av Stacy Coen
| Företag | Position | Slut |
|---|---|---|
| FIBROBIOLOGICS, INC. | Direktör/Styrelseledamot | 2026-06-22 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Företagsledare/Principal | - |
| EDITAS MEDICINE, INC. | Företagsledare/Principal | - |
Stacy Coens utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
54
Första gradens relationer
9
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 9 |
|---|---|
ImmunoGen, Inc.
 ImmunoGen, Inc. BiotechnologyHealth Technology Develops anticancer therapeutics | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Commercial Services |
Huntington's Disease Society of America | Commercial Services |
Alliance for Regenerative Medicine
Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
Editas Medicine, Inc.
 Editas Medicine, Inc. BiotechnologyHealth Technology Manufactures gene editing medicines | Health Technology |
University of Virginia Darden School of Business
 University of Virginia Darden School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
FibroBiologics, Inc.
 FibroBiologics, Inc. BiotechnologyHealth Technology Develops and commercializes fibroblast-based cell therapies | Health Technology |
